Sutro Biopharma announced the promotion of Jane Chung to President and Chief Operating Officer, a newly created role, effective December 1. In this newly created position, Ms. Chung will be responsible for driving operational excellence, strategic growth, and overall business
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on STRO:
- Sutro Biopharma Promotes Jane Chung to President and Chief Operating Officer
- Sutro Biopharma price target lowered to $12 from $18 at Piper Sandler
- Sutro Biopharma files $300M mixed securities shelf
- Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
- Sutro Biopharma initiated with a Buy at Deutsche Bank
